Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ursula Bowler is active.

Publication


Featured researches published by Ursula Bowler.


Health Technology Assessment | 2016

A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Guidance sheet 3: preparation and administration of the trial intervention

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Probiotics in Preterm infantS trial sites

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Form 1: trial entry

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Parent information leaflet version 5.1

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Form 4: abdominal pathology

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Form 2: daily data

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Form 6: intervention discontinuation or trial withdrawal

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Form 5: for reporting serious adverse events and suspected unexpected serious adverse reactions

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar


Archive | 2016

Consent form version 3.1

Kate Costeloe; Ursula Bowler; Peter Brocklehurst; Pollyanna Hardy; Paul Heal; Edmund Juszczak; Andrew J. King; Nicola Panton; Fiona Stacey; Angela Whiley; Mark Wilks; Michael Millar

Collaboration


Dive into the Ursula Bowler's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Angela Whiley

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fiona Stacey

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

Kate Costeloe

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nicola Panton

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

Paul Heal

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge